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Reproductive aging is characterized by delayed and attenuated luteinizing hormone (LH)
surges apparent in middle-aged rats. The suprachiasmatic nucleus (SCN) contains the
circadian clock that is responsible for the timing of diverse neuroendocrine rhythms. Elec-
trophysiological studies suggest vasoactive intestinal peptide (VIP) originating from the
SCN excites gonadotropin-releasing hormone (GnRH) neurons and affects daily patterns of
GnRH–LH release. Age-related LH surge dysfunction correlates with reduced VIP mRNA
expression in the SCN and fewer GnRH neurons with VIP contacts expressing c-fos, a
marker of neuronal activation, on the day of the LH surge. To determine if age-related
LH surge dysfunction reﬂects reducedVIP availability or alteredVIP responsiveness under
estradiol positive feedback conditions, we assessed the effect of intracerebroventricular
(icv)VIP infusion on c-fos expression in GnRH neurons and on LH release in ovariohysterec-
tomized, hormone-primed young and middle-aged rats. Icv infusion of VIP between 1300
and 1600h signiﬁcantly advanced the time of peak LH release, increased total and peak
LH release, and increased the number of GnRH neurons expressing c-fos on the day of
the LH surge in middle-aged rats. Surprisingly, icv infusion ofVIP in young females signiﬁ-
cantlyreducedthenumberofGnRHneuronsexpressingc-fosanddelayedandreducedthe
LH surge. These observations suggest that a critical balance of VIP signaling is required
to activate GnRH neurons for an appropriately timed and robust LH surge in young and
middle-aged females. Age-related LH surge changes may, in part, result from decreased
availability and reducedVIP-mediated neurotransmission under estradiol positive feedback
conditions.
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INTRODUCTION
An appropriately timed and robust preovulatory gonadotropin-
releasing hormone (GnRH)–luteinizing hormone (LH) surge in
rodents requires the convergence of synchronized neurochemical
and hormonal events. Female reproductive aging is characterized
by reduced responsiveness to estrogen positive feedback, result-
ing in a delayed and attenuated preovulatory LH surge (Cooper
et al., 1980; Wise, 1982). Age-related changes in the magnitude
of the LH surge reﬂect dysregulation of estradiol-regulated hypo-
thalamic neurotransmission, which includes increased inhibitory
input from GABA, reduced excitatory input from glutamate and
kisspeptin, and reduced insulin-like growth factor-1 signaling
(Neal-Perry et al., 2008, 2009; Lederman et al., 2010; Todd et al.,
2010; Sun et al., 2011).
The suprachiasmatic nucleus (SCN) is hypothesized to inte-
grate and synchronize all of the diverse neuroendocrine events
required to activate GnRH neurons and to initiate an appropri-
ately timed GnRH–LH surge (Brown-Grant and Raisman, 1977;
Wiegand and Terasawa, 1982; Van der Beek et al., 1997; Colwell
et al.,2003; de la Iglesia and Schwartz,2006).Vasoactive intestinal
peptide(VIP)neuronsandvasopressin(AVP)positivecellslocated
in the ventrolateral and dorsomedial SCN (Card et al., 1988)a r e
hypothesized to be principal mediators of SCN modulation of
the LH surge (van der Beek et al., 1993, 1994; Palm et al., 1999;
Miller et al.,2006;Tsukahara,2006). Moreover,available data sug-
gest that a critical level of AVP and VIP signaling are required for
appropriately timed LH pulse frequencies and induction of the
LH surge under estradiol positive feedback conditions (Alexander
et al., 1985; Harney et al., 1996; Krajnak et al., 1998; Palm et al.,
1999; Colwell et al., 2003; Miller et al., 2006). Consistent with
this hypothesis, icv infusion of AVP rescued LH release in trans-
genic mice with a mutation in the core circadian gene CLOCK
and rescues the amplitude of the LH surge in rats that have AVP
lesions in the SCN. Moreover VIP neurons located in the SCN
projecttoGnRHneurons(VanderBeeketal.,1997),VIPactivates
GnRH neurons in a time- and estradiol-dependent fashion (van
der Beek et al., 1994; Krajnak et al., 2001; Christian and Moen-
ter, 2008), and VIP receptors are expressed on GnRH neurons
and on astrocytes that are in close apposition to and ensheath
GnRH neurons (Smith et al., 2000; Gerhold and Wise, 2006).
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Additionally, exogenous infusion of VIP into the brain induces
GnRH (Samson et al., 1981) and LH release in estradiol-primed
females with SCN lesions (Palm et al., 1999). Conversely, intrac-
erebroventricular(icv)infusionofVIPantiseruminintactfemales
orVIPinfusioninovariectomizedfemalesbluntstheLHsurgeand
LH pulses, respectively (Alexander et al., 1985; Weick and Stobie,
1992, 1995).
Of interest, changes in the LH surge in old, irregularly cycling
and persistent diestrus female rats correlate with reduced c-fos
expression in SCN neurons, reduced VIP mRNA expression in
the SCN, and reduced activation of GnRH neurons receiving VIP
contacts (Krajnak et al.,1998,2001).Additionally,the LH surge in
young rats is delayed and attenuated by infusion ofVIP antiserum
into the third ventricle (van der Beek et al.,1999),infusion of VIP
antisense oligonucleotides into the SCN (Harney et al., 1996), or
thermal ablation of VIP neurons in the SCN (van der Beek et al.,
1993).IncontrastAVPmRNAexpressionintheSCNof reproduc-
tively aging females does not change (Krajnak et al., 1998). These
dataledustohypothesizethatthedelayedandattenuatedLHsurge
inregularlycycling,middle-agedratsresultsfromreducedrespon-
siveness to VIP, and/or reduced availability of VIP at the time of
the surge. To test this hypothesis we (1) determined if hypothala-
micVIPmRNAlevelsinregularlycyclingmiddle-agedfemalesare
signiﬁcantlylessthaninyoungfemalesonthedayof theLHsurge;
(2) determined if icv infusion of VIP rescues LH surge amplitude
and/or restores the timing of the LH surge in regularly cycling
middle-aged females; and (3) determined if icv infusion of VIP
restores the activation of GnRH neurons, as determined by c-fos
co-expression, in middle-aged females.
MATERIALS AND METHODS
ANIMALS AND HORMONE ADMINISTRATION
Young (2–3months) and middle-aged (retired breeders, 9–
11months)femaleSprague-Dawleyrats(TaconicFarms,German-
town, NY, USA) were housed individually and maintained on a
14-h light, 10-h dark cycle (lights on at 0600) with free access to
chowandwater.Onlyratswithatleasttworegular4–5dayestrous
cycles were used. All procedures followed the National Institutes
of Health Guide for the Care and Use of Laboratory Rats and were
approved by the Institutional Animal Care and Use Committee
at the Albert Einstein College of Medicine. All studies conditions
weredoneinparallel.ToinduceLHsurges,estradiolbenzoate(EB)
and progesterone (P; Steraloids Inc.,Newport,RI,USA) were dis-
solvedinpeanutoilandadministeredsubcutaneouslyinavolume
of 0.1ml. At 0900hours 7days after ovariohysterectomy (OVX)
and cannula placement, rats received the ﬁrst of two daily injec-
tionsof2μgofEB.At0900hours2daysaftertheﬁrstEBinjection,
ratswereinjectedwith500μgof P.Thishormoneregimenreliably
produces LH surges in 75–80% of OVX female rats (Neal-Perry
et al.,2005).
CANNULA PLACEMENT AND JUGULAR VEIN CATHETERIZATION
ForOVXandstereotaxicsurgery,ratswereanesthetizedwithintra-
muscular ketamine/xylazine (80 and 4mg/kg, respectively). After
OVX, they were placed in a Kopf stereotaxic apparatus. A 22-
gage icv guide cannula (Plastics One, Roanoke, VA, USA) was
placedintothethirdventricle(A/P+0.2mm;M/L+0.0mm;D/V
−9.8mm relative to Bregma) and plugged with a 26-gage dummy
that extended 1mm below the guide (Todd et al., 2010). Animals
recovered for 6- to 7-days before further manipulations. Correct
guide cannula placement was veriﬁed by tracking the path of the
cannula in brain sections at the time of immunohistochemistry
(IHC). Only those rats with correct placement of the icv cannulae
were included in data analysis.
An indwelling catheter for serial blood sampling was placed
in the jugular vein of anesthetized females 7days after OVX
and stereotaxic surgery as previously described (Neal-Perry
et al., 2005). Catheters were kept patent by daily ﬂushing with
heparinized saline (50IU). Blood collection (300μl/sample) was
initiated 2days after the ﬁrst EB injection starting at the time
of the P injection and then every 2h for 12h. Blood was col-
lected into tubes containing heparinized saline (10IU), refriger-
ated overnight, and centrifuged at 10,000×g for 20min. Plasma
was stored at −80˚C until assayed for LH. An equal volume of
warmed saline was infused after each blood collection to avoid
hypovolemia.
ICV DRUG ADMINISTRATION
Normal saline was used to dissolve drugs and infused into all
control rats. Two days after the ﬁrst EB injection, the rats were
connected to an automatic pump (Bioanalytical System Inc.,West
Lafayette, IN, USA) and attached to a tether allowing rats to
move freely. Twenty micrograms of human VIP peptide (6nmol;
Bachem, CA, USA) or saline (vehicle/control) was infused into
the third ventricle of young and middle-aged rats between 1300
and 1600h at 2nmol/15μl/h, the time of the LH surge in young,
reproductive-aged females (Neal-Perry et al., 2005).
LH RADIOIMMUNOASSAY
Plasma LH concentrations were measured in duplicate with rat
double-antibody assays reagents provided by the Reproduction
LigandAssayandAnalysisCore,GeneralClinicalResearchCenter,
University of Virginia (Charlottesville,VA, USA). The lower limit
of theLHassaywas0.04ng/mlandtheintra-andinter-assaycoef-
ﬁcients of variation were 3.9 and 5.7%, respectively. An LH surge
wasdeﬁnedasgreaterthanorequaltoa1.5-foldincreaseinserum
LH levels from baseline for a minimum of two consecutive sam-
ples, and surge onset was considered to occur at the ﬁrst of these
samples(Toddetal.,2010).BaselineLHlevelsaredeﬁnedbythose
at the time of P injection. Only those females who demonstrated
an LH surge were included in the data analysis.
HYPOTHALAMIC DISSECTION, RNA PURIFICATION, REVERSE
TRANSCRIPTION, AND REAL-TIME PCR FOR VIP
Independent groups OVX, young (n =5–7), and middle-aged
(n =5–7) rats were primed with oil (control/vehicle) or EB and
P as described above. Rats were killed 4h after the P or last oil
injection. The hypothalamus was dissected into anterior and pos-
teriors halves (Neal-Perry et al.,2008),snap frozen on dry ice,and
stored at −80˚C until determination of VIP mRNA levels. DNA-
freetotalRNAwaspuriﬁedusingtheRNeasylipidminikit(Qiagen,
Valencia, CA, USA) including a deoxyribonuclease step. Reverse
transcription (RT) was performed using the high-capacity cDNA
RT kit with ribonuclease inhibitor (Applied Biosystems, Foster
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City, CA, USA) using 500ng of RNA. Gene expression was mea-
sured by real-time PCR using TaqMan gene expression assays and
master mix (Applied Biosystems) according to the manufacturer’s
instructions. 18S ribosomal RNA (18S rRNA, Fam probe, refer-
ence sequence Hs99999901_s1, context sequence X03205.1) was
the endogenous control for VIP (Fam probe, reference sequence
Rn01430567_m1; context sequence NM_053991.1). Real-time
PCR was performed using an ABI PRISM 7900HT (Applied
Biosystems)insimplexconditionsusing50ngofcDNA.Ampliﬁed
transcripts forVIP were quantiﬁed using the comparative thresh-
old cycle method and 18S rRNA as normalizer. The fold change in
VIP expression was calculated as 2−ΔΔCT where CT=threshold
cycle,ΔCT=CT (VIP) – CT (18S rRNA),ΔΔCT=ΔCT (exper-
imental)–ΔCT(reference).ΔCT(reference)wascalculatedusing
the mean of the ΔCT for the hypothalamus of OVX controls
treated with oil.
IHC FOR GnRH AND c-fos
As per a modiﬁed protocol of Hoffman et al. independent groups
of animals were perfused with 4% paraformaldehyde and 2.5%
acrolein in phosphate buffer (pH 6.8) after VIP infusion between
1600 and 1730h on the expected day of the LH surge (Hoff-
man and Le, 2004; Sun et al., 2011). Brains were post-ﬁxed in
4% paraformaldehyde overnight at 4˚C, and then placed in 30%
sucrose until they sank. This ﬁxative method affords advantages
that include improved antigen retrieval and improved signal to-
noise ratios. Six sets of coronal sections (30μm) starting at the
level of the organum vasculosum of lamina terminalis (Bregma
+0.48mm) and continuing through the medial preoptic area
(POA; Bregma −0.72mm) were collected from each animal, with
each set containing every sixth section. Sections were stored
in cryoprotectant at −20˚C until processed for immunolabeling
(Hoffman and Le, 2004).
As previously described (Sun et al., 2011) tissue sections were
rinsed in potassium phosphate buffered saline (KPBS,0.05M,PH
7.4) to remove cryoprotectant, incubated in 1% sodium borohy-
drate to remove acrolein and then 3% H2O2 for 10min to block
endogenous peroxidase activity. Sections were subsequently incu-
batedinKPBSplus0.04%Triton-X100(KPBS–Tx)and1%bovine
serum albumin (BSA) for 1h at room temperature. Sections were
incubatedingoatanti-c-fosantibody(1:1000,SantaCruzBiotech-
nology Inc., Santa Cruz, CA, USA) in KPBS–Tx and 1% BSA
for 48h at 4˚C next and then incubated in biotinylated anti-goat
immunoglobulin G (IgG,1:600,Vector Laboratories,Burlingame,
CA, USA) in KPBS–Tx for 1h at room temperature. Finally
sectionswererinsedandincubatedfor1hinavidinbiotincomplex
(‘Elite’ ABC kit, Vector Laboratories). After rinsing in KPBS and
0.175M sodium acetate, the sections were stained in nickel sul-
fate (25mg/ml) and diaminobenzidine–HCl (DAB,0.2mg/ml) in
0.175Msodiumacetatecontaining30%H2O2 for10minfollowed
byaﬁnalrinseinKPBSandsodiumacetate.C-fosimmunoreactive
(ir) neurons were visualized as blue–black in the nuclei of neu-
rons.Forcolocalizationofc-fosinGnRHneurons,thesequenceof
reactions was repeated, substituting rabbit-anti GnRH antiserum
as the primary antibody (1:5000, LR-5, a generous gift from Dr.
R. Benoit, McGill University, Montreal, Canada) for 24h at 4˚C.
After rinsing, sections were incubated in biotinylated anti-rabbit
IgG (Vector Laboratories) diluted (1:600) in KPBS–Tx for 1h at
roomtemperature,rinsed,andreactedwiththeavidinbiotincom-
plex as described above.A mixture of H2O2 and DAB–HCl in Tris
(Sigma Aldrich Inc., St. Louis, MO, USA; 0.05M, pH 7.2) was
used as the chromogen to yield a brown staining in the cytoplasm.
Sections were mounted onto Superfrost Plus slides (Fisher Scien-
tiﬁc, Pittsburgh, PA, USA). After drying overnight, the sections
were dehydrated with ascending alcohol concentrations, cleared
with xylenes, and coverslipped. A series of tissue sections was
treated identically except without primary antibody to control for
antibody speciﬁcity.
QUANTIFICATION GnRH AND c-fos-IMMUNOPOSITIVE CELLS
To quantify GnRH and c-fos-ir neurons, ﬁve sections of POA in
the 1-in-6 series were viewed under a microscope (Zeiss Axiover-
sion, Carl Zeiss, Thornwood, NY, USA; Sun et al., 2011). Sections
corresponded to Plates 30–35 of the Paxinos and Watson atlas.
Cells were considered c-fos-ir if they had blue/black nuclear
staining with distinct nuclear boundaries. GnRH-ir cells were
counted when the cell body was clearly identiﬁed and if they had
browncytoplasmicstaining.GnRHneuronsexpressingc-foswere
countedat40×magniﬁcation;ifcellshadbothbrowncytoplasmic
and blue/black nuclear staining, they were considered to be dou-
ble labeled (Figures 3A–H). Cell counting was performed by two
countersblindedtotreatment(inter-ratervariation<10.5%)and
averagecellcountsreported.TotalGnRHandc-fosneuronsaswell
as the percent of GnRH neurons expressing c-fos were calculated.
STATISTICAL ANALYSIS
Data are expressed as mean±SEM. The area under the curve
(AUC) for total LH release was calculated using Sigma Plot 10.0
(Systat Software,Inc.,Chicago,IL,USA).A mixed design two-way
ANOVA was used to determine the effect of time (repeated mea-
sure) and VIP (independent measure) on LH release. Two-way
ANOVA (age×treatment) was used to determine differences in
VIPmRNAandintotalLH,GnRH,andc-foscellnumbersandper-
cent of GnRH neurons expressing c-fos. P <0.05 was considered
statistically signiﬁcant. Non-parametric testing was used when
datawerenotnormallydistributed.BonferroniorNewman–Keuls
post hoc tests were performed as appropriate.
RESULTS
LH SURGES AND HYPOTHALAMIC VIP mRNA EXPRESSION IN YOUNG
AND MIDDLE-AGED RATS
The EB and P-induced LH surge is delayed and attenuated in
middle-aged rats compared to young rats (Figures 1A,B). Pre-
vious studies suggest that circadian-related changes in VIP cells
of the SCN regulate the onset and peak of LH release in young
rats (Colwell et al.,2003). Moreover,in situ hybridization suggests
that old, irregularly cycling middle-aged, and persistent diestrus
females have reduced VIP mRNA levels in the SCN and the POA
on the day of the LH surge. To determine if hormone treatment
affects hypothalamic VIP mRNA expression in regularly cycling,
middle-aged females, we quantiﬁed VIP mRNA expression lev-
els in the hypothalamus of a separate group of OVX control
and EB+P-primed young and middle-aged females by real-time
PCR. Neither age nor hormone treatment signiﬁcantly affected
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FIGURE 1 | HypothalamicVIP mRNA expression is not reduced in
regularly cycling, middle-aged females with delayed and attenuated LH
surges. OVX young (Y; n=6) and middle-aged (MA; n=6) female rats
received two daily doses of E2 benzoate (E: 2μg) and one injection of
progesterone (P: 500μg) on the day of serum collection, or vehicle (oil). Serial
blood sampling started at the time of P injection and continued every 2h for
12h.Time 0 represents the time of the P injection. Separate rats were used in
RT-PCR experiments and were killed 52h after the ﬁrst injection of oil or E.
Data are expressed as mean±SEM. (A) LH surge in young (•) and
middle-aged females () infused with icv saline. (B) Scatter plots of LH surge
onset in young (◦) and middle-aged females () infused with icv saline. (C)
Scatter plots of VIP mRNA expression levels in the anterior hypothalamus of
young (◦,•; n=6–7) and middle-aged (, ; n=5–6) rats primed with
E+P(•, ) or oil (◦, ). (D) Scatter plots of VIP mRNA expression levels in
the posterior hypothalamus of young (◦,•; n=5–7) and middle-aged (, ;
n=4–7) rats primed with E+P(•, ) or oil (◦, ).
aP <0.05 vs. middle-aged.
total VIP mRNA levels in the anterior or posterior hypothalamus
(Figures 1C,D).
ICV INFUSION OF VIP RESTORES LH SURGE AMPLITUDE AND
ADVANCES PEAK RELEASE OF LH IN MIDDLE-AGED RATS
OVX,EB+P-primedratswereinfusedcontinuouslywithsalineor
VIP(6nmoltotaldose)between1300and1600honthedayof the
LHsurge.TherewasasigniﬁcantinteractionbetweenageandVIP
treatment on total LH and peak LH release (P <0.01). Middle-
aged females infused with VIP exhibited a greater than twofold
increase in total (Figure 2C; P <0.01) and peak LH (Figure 2E;
P <0.01) release compared to middle-aged controls infused with
saline.Moreover,VIPinfusionrescuedpeakandtotalLHreleasein
middle-aged females to levels that were equivalent to young con-
trol females (Figures 2A–C,E). VIP infusion did not advance the
onset of the LH surge (Figure 2D); however, the time of peak LH
release was signiﬁcantly advanced in middle-aged females infused
withVIP (Figure 2F; P <0.03).
ICV INFUSION OF VIP ATTENUATES AND DELAYS THE LH SURGE IN
YOUNG RATS
Young females infused with VIP had attenuated peak LH levels
(P <0.05)andreleasedapproximately2/3lesstotalLH(P <0.01)
than young controls (Figures 2A,E). Peak LH release (P <0.05)
andtheonsetof theLHsurge(P <0.05)weresigniﬁcantlydelayed
inVIP-infused young rats (Figures 2D,F).
VIP INFUSION INCREASES THE PERCENT OF GnRH NEURONS
EXPRESSING c-fos AND NUMBERS OF c-fos-ir NEURONS IN THE POA
OF MIDDLE-AGED FEMALES
To determine if icv infusion of VIP increased the number of acti-
vatedGnRHneurons,wequantiﬁedthepercentof GnRHneurons
expressing c-fos, a marker of neuronal activation, in hormone-
primed middle-aged females infused with VIP. The number of
GnRH neurons in middle-aged females infused withVIP or saline
was not signiﬁcantly different (Figure3J). Similar to our previous
study (Sun et al., 2011), approximately 20% of GnRH neurons
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FIGURE 2 | Icv infusion ofVIP restores the LH surge in middle-aged
females but delays and attenuates the LH surge in young females. Data
are expressed as mean±SEM. OVX young (Y; n=6) and middle-aged (MA;
n=6) rats were primed with two daily doses of E (2μg) and one injection of P
(500μg) on the day of serum collection and infused with saline (control) orVIP
(6nmol) between 1300 and 1600h. Serial blood sampling started at the time
of P injection and continued every 2h for 12h.To compare the effect of VIP
infusion on LH release in control females, we included the LH surge data for
young and middle-aged, saline infused E+P-primed females shown in
Figure 1. (A) LH surge in young females infused icv with saline (◦) or VIP
(•). (B) LH surge in middle-aged females infused icv with saline () or VIP
(). (C) Scatter plots of total LH release [area under the curve (AUC); ng/ml/h]
in young (◦,•) and middle-aged (, ) females infused with icv saline (◦,
) or VIP (•, ). (D) Scatter plots of LH surge onset in young (◦,•) and
middle-aged (, ) females infused with icv saline (◦, ) or VIP (•, ). (E)
Scatter plots of peak LH release in young (◦,•) and middle-aged (, )
females infused icv with saline (◦, ) orVIP (•, ). (F) Scatter plot of time to
peak LH release in young (◦,•) and middle-aged (, ) females infused
with icv saline (◦, ) or VIP (•, ).
aP <0.05 vs. saline infused young rats.
bP <0.05 vs. saline infused young and VIP-infused middle-aged rats.
in the EB+P-primed middle-aged rats express c-fos (Figure 3I).
Middle-aged rats primed with EB+P and infused withVIP had a
threefold increase (P <0.01) in the number of GnRH neurons
expressing c-fos (Figure 3I). Additionally, icv infusion of VIP
signiﬁcantly increased the total number of c-fos-ir neurons in
the POA of middle-aged rats by more than threefold (P <0.001;
Figure 3K).
VIP INFUSION DECREASES THE PERCENT OF GnRH NEURONS
EXPRESSING c-fos AND THE NUMBERS OF GnRH-ir NEURONS IN
YOUNG FEMALES
WealsodeterminedifVIPinfusionmodiﬁesthepercentof GnRH
neurons activated in young females (Figures 3A–H). Consistent
with our previous work (Sun et al., 2011), approximately 53% of
GnRH neurons in young females express c-fos under hormonal
conditions that typically induce a robust LH surge (Neal-Perry
et al.,2005; Figure3I). Compared to young control females,infu-
sion of VIP signiﬁcantly reduced the percent of GnRH neurons
expressing c-fos by about 50% (P <0.05; Figure 3I)t ol e v e l s
that were not signiﬁcantly different than control middle-aged
females (Figure 3I). Surprisingly, icv infusion of VIP signiﬁcantly
decreased the number of GnRH-ir neurons (P <0.05; Figure 3J).
Unlike middle-aged females,icv infusion of VIP in young females
didnotsigniﬁcantlyaffectc-fosexpressioninnon-GnRHneurons
(Figure 3K).
DISCUSSION
These data strongly suggest that a critical level of VIP signal-
ing in the brain is important for an appropriately timed and
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FIGURE 3 | Icv infusion ofVIP increased numbers of GnRH/c-fos-ir
and c-fos-ir neurons and decreased the number GnRH-ir and
GnRH/c-fos-ir in the POA of middle-aged and young females,
respectively. Middle-aged (MA; n=4) and young (Y; n=4) OVX rats
primed with E (2μg) and one injection of P (500μg) on the day of serum
collection were infused icv with saline (control) or VIP (6nmol) between
1300 and 1600h and then perfused between 1600 and 1730h. Data are
presented as mean±SEM. Representative sections of double-label
immunohistochemistry (20× and 40× magniﬁcation) showing GnRH
neurons (brown cytoplasm) with c-fos-ir nuclei (black) in rats infused with
saline (A,B,E,F) or VIP (C,D,G,H). Open arrowhead indicate GnRH
neurons. Closed arrowheads indicate GnRH neurons expressing c-fos.
Scale bars, 10μm. (I) Scatter plots of the percent of GnRH neurons
expressing c-fos-ir in POA of young (◦,•) and middle-aged (, ) rats
infused with saline (◦, ) or VIP (•, ). (J) Scatter plots of the total
number of GnRH-ir neurons in the POA of young (◦,•) and middle-aged
(, ) rats infused with saline (◦, ) or VIP (•, ). (K) Scatter plots of
the total number of c-fos-ir cells in the POA of young (◦,•) and
middle-ages (, ) rats infused with saline (◦, ) or VIP (•, ).
aP <0.05 vs. saline infused young and VIP-infused middle-aged rats.
bP <0.05 vs. saline infused young females.
cP <0.05 vs. saline infused
young and young and middle-aged females infused with VIP .
robust LH surge in middle-aged rats. We hypothesized that age-
related LH surge changes result from reduced release of cen-
tral VIP rather than reduced synthesis of or responsiveness to
the peptide. Consistent with our hypothesis, we found that the
delayed and attenuated LH surge observed in regularly cycling
middle-aged females is not associated with reduced hypothal-
amic VIP mRNA expression levels. Moreover, icv infusion of
VIP in middle-aged, hormone-primed females rescued total and
peak LH and the time of peak LH release. Icv infusion of
VIP also increased the number of GnRH and non-GnRH neu-
rons expressing c-fos to levels signiﬁcantly greater than control
middle-aged rats and equivalent to young controls. Icv infusion
of VIP did not advance the onset of the LH surge in middle-
aged females. Taken together, these ﬁndings are consistent with
others suggesting that reduced VIP neurosignaling delays and
attenuates the LH surge (Krajnak et al., 1998, 2001). They also
strongly suggest that age-related changes in the LH surge reﬂect,
in part, reduced release of VIP and not reduced responsiveness
of middle-aged females to VIP under estradiol positive feedback
conditions.
In contrast to its effects in middle-aged females,icv infusion of
VIP does not advance the onset or increase the peak amplitude of
theLHsurgeinyoungrats.Insteadwedemonstratethatincreased
brain VIP levels impose an opposite effect on young females.
VIP infusion signiﬁcantly reduced the percent of GnRH neurons
expressing c-fos,delayed the onset of the LH surge and attenuated
peak LH release in young females, thus creating a LH surge pat-
ternreminiscentofonetypicallyobservedinmiddle-agedfemales.
These data strongly suggest that, a critical level of VIP signaling
is required in females to maintain appropriately timed and high
amplitude preovulatory LH surges.
VIP mRNA EXPRESSION IN YOUNG AND MIDDLE-AGED
HORMONE-PRIMED FEMALES
Neurons located in the SCN are hypothesized to regulate the
circadian signal driving the daily LH surge in rodents (Brown-
Grant and Raisman, 1977). GnRH neurons express VIP receptors
(Smith et al., 2000), and VIP neurons in the SCN are hypothe-
sized to project to 45% of GnRH neurons and to activate GnRH
neurons in an estradiol- and time-dependent fashion (van der
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Beek et al., 1993; Van der Beek et al., 1997; Christian and Moen-
ter,2008). Studies using in situ hybridization suggest that reduced
expression of VIP mRNA in the SCN correlates with the reduced
amplitude and delayed onset of LH surges in middle-aged rats
(Harney et al., 1996; Krajnak et al., 1998). Consistent with these
experiments the administration of VIP antiserum or VIP anti-
sense oligonucleotide in young reproductive-aged females delays
and attenuates the LH surge (Harney et al., 1996; van der Beek
et al., 1999). We used quantitative RT-PCR to determine if age
and/or hormone treatment signiﬁcantly affected totalVIP expres-
sion in anterior hypothalamus (location of the majority of GnRH
neurons contacted by VIP terminals) or the posterior hypothala-
mus(locationof theSCNandthemajorityof theVIPsynthesizing
neurons in this region). To our surprise we did not ﬁnd a signif-
icant age-related difference in anterior or posterior hypothalamic
VIP mRNA expression, thereby suggesting age-related changes in
the LH surge do not correlate with reduced hypothalamic VIP
mRNAlevelsinmiddle-agedfemalesthatstillhaveregularestrous
cycles.Theseﬁndingsdifferfrompriorstudiesthatreportreduced
VIP mRNA expression in the hypothalamus of irregularly cycling
middle-aged and persistent diestrus old females (Krajnak et al.,
1998). The main difference in our study and earlier studies is
that we determined hypothalamic VIP mRNA levels in regularly
cycling females instead of irregularly cycling (Krajnak et al.,1998)
or persistent diestrus old females (Krajnak et al., 2001). Thus, it
is possible that females with regular estrous cycles have not yet
reached a stage whenVIP mRNA synthesis declines. Alternatively,
it is possible that changes in VIP mRNA expression are local-
ized to the SCN and our technical approach does not detect ﬁne
local changes in SCN (Panda et al., 2002). Thus, it is possible
that age-related differences in VIP expression in regularly cycling
middle-aged females would be detected with microdissection of
the SCN.
VIP PROMOTES A HIGH AMPLITUDE LH SURGE AND ACTIVATION OF
GnRH NEURONS IN MIDDLE-AGED FEMALES
Age-related changes in the LH surge correlate with changes in the
rhythmic expression of VIP mRNA and reducedVIP mRNA con-
tentintheSCN(Krajnaketal.,1998).Additionally,age-relatedLH
surgedysfunctioninirregularlycyclingmiddle-agedandpersistent
diestrus old females is hypothesized to reﬂect reduced responsive-
ness to VIP, because reduced numbers of VIP-innervated GnRH
neurons express c-fos on the day of the LH surge (Krajnak et al.,
1998). Although we did not observe a signiﬁcant reduction in
hypothalamicVIP mRNA levels,it is still possible that age-related
changes in the LH surge reﬂect reduced availability or release of
VIP or altered responsiveness toVIP under estrogen positive feed-
back conditions (Krajnak et al., 2001). To address this question,
we infused VIP into the third ventricle of middle-aged hormone-
primed females and assessed onset and time of peak LH release,
total and peak LH release, the percent of GnRH and non-GnRH
neurons expressing c-fos in the POA. Icv infusion of VIP did not
signiﬁcantly advance the onset of the LH surge in middle-aged
females. However, VIP signiﬁcantly increased total and peak LH
release and advanced the time of peak LH release in middle-aged
females to levels seen in young controls. These in vivo experi-
ments strongly support the hypothesis that reduced availability of
VIP and not reduced responsiveness to VIP under estradiol posi-
tivefeedbackconditionscontributestothedelayedandattenuated
LH surge in regularly cycling, middle-aged females. Additionally,
becausewedidnotdemonstrateanage-relatedreductioninhypo-
thalamicVIP mRNA levels,reduced availability of VIP most likely
reﬂectsreducedVIPreleaseratherthanreducedpeptidesynthesis.
This may also explain why signiﬁcant numbers of GnRH neu-
ronswithVIPcontactsinmiddle-agedfemalesfailtoexpressc-fos
on the day of the LH surge (Krajnak et al., 2001). Interestingly,
although VIP infusion advanced the time of peak LH release, it
did not advance LH surge onset. These data suggest that timing of
peak LH release and the onset time of the surge may be differen-
tially regulated by VIP or that reduced VIP only partially explains
age-related LH surge dysfunction.
Electrophysiological studies suggest thatVIP stimulates GnRH
neurons (Christian and Moenter, 2008). Consistent with electro-
physiological studies, anatomical studies show as much as 60%
of GnRH neurons with VIP contacts express c-fos on the day of
the LH surge (Krajnak et al., 2001). Thus, we determined if VIP-
inducedLHreleasecorrelateswithincreasedGnRHornon-GnRH
neuronal activation in the POA on the day of the LH surge. Icv
infusion of VIP increased the number of c-fos-expressing GnRH
and non-GnRH neurons, thereby strongly suggesting that age-
related LH surge dysfunction involves suboptimalVIP-dependent
activation of hypothalamic neurons involved in the induction of
the LH surge. Although our studies strongly suggest that VIP
affects LH release in middle-aged rats by activating GnRH neu-
rons, it is possible that the peptide increases LH by modulating
GnRH release from axon terminals (Samson et al., 1981). Alter-
natively, because VIP also signiﬁcantly increased c-fos expres-
sion in non-GnRH neurons, icv infusion of VIP may increase
LH release in middle-aged rats by indirect activation of GnRH
neurons.
The mechanisms resulting in reduced VIP neurotransmission
in middle-aged females are unknown. We have demonstrated
that female reproductive aging is characterized by reduced gluta-
matergicandincreasedGABAergicneurotransmissioninthePOA
(Neal-Perry et al., 2005, 2008). VIP neurons located in the SCN
receive glutamatergic afferents from the POA (Kiss et al., 2008).
Thus it is possible that reduced availability of VIP peptide results
from reduced excitatory afferent input to VIP neurons from glu-
tamatergic neurons located in POA. Several studies have demon-
strated that AVP neurosignaling is important for high amplitude
LH surges in young reproductive-aged females (Palm et al., 1999;
Miller et al., 2006). Our studies do not rule out the possibility
that altered AVP neurosignaling also contributes to age-related
LHsurgedysfunction.Additionalstudiesarerequiredtotestthese
hypotheses.
ADVERSE EFFECTS OF VIP ON ACTIVATION OF GnRH NEURON
AND LH RELEASE
Several studies report that continuous VIP infusion in young
reproductive-agedfemalesreducesLHpulsefrequencyandblocks
theLHsurge(Alexanderetal.,1985;Akemaetal.,1988;Weickand
Stobie, 1995). Consistent with other reports we found VIP infu-
sion signiﬁcantly decreased LH release in young rats (Weick and
Stobie, 1992). VIP infusion also attenuated and delayed peak LH
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release and the LH surge onset. Icv infusion of VIP also reduced
the number of GnRH neurons co-expressing c-fos from 54 to
19%. To our surprise, VIP also signiﬁcantly reduced numbers of
GnRH-ir neurons. One interpretation of these data is that VIP
reduced GnRH–LH release by reducing GnRH peptide expres-
sion and activation of GnRH neurons. The cellular mechanism(s)
responsible for this surprising ﬁnding is (are) unclear. One other
study reported a similar ﬁnding in seasonal breeding juncos in
which the number of VIP-ir neurons inversely correlated with the
number of GnRH-ir neurons; photosensitive (breeding) juncos
have a low ratio of VIP-to-GnRH-ir neurons, and photorefrac-
tory (non-breeding) juncos have a high ratio of VIP-to-GnRH-ir
neurons (Saldanha et al.,1994).
CONCLUSION
Previous studies in irregularly cycling middle-aged and persistent
diestrus females suggest that delayed and attenuated LH surges
might result from reduced hypothalamic VIP levels and respon-
siveness to VIP. This study strongly supports the hypothesis that
age-relatedLHsurgedysfunctioninregularlycyclingmiddle-aged
females most likely reﬂects reducedVIP release and not abnormal
responsiveness toVIP. Considerable evidence suggests age-related
changes in the timing and magnitude of the LH surge in regularly
cycling middle-aged females is associated with the failure of ovar-
ian steroids to regulate a number of neurotransmitter systems
involved in GnRH neuron activation. The cellular mechanism(s)
that result in reduced VIP release may reﬂect age-related reduced
responsivenesstoestradiolofVIPcontainingneuronsintheSCN.
In contrast with ﬁndings in middle-aged rats, infusion of VIP in
youngfemalesattenuatesanddelaystheLHsurge,andthisisasso-
ciated with reduced activation and reduced numbers of GnRH-ir
neurons. These studies suggest that a critical level of VIP signal-
ing is required for the maintenance of an appropriately timed and
robust LH surge.
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